Extraneuronal Monoamine Transporter Expression in Human Tumor Cell Lines

Zhong Chen

1999-01-01

Chinese Journal of Cancer

Abstract:Objective:We previously have found that 2 chloroethyl 3 sarcosinamide 1 nitrosourea (SarCNU),a new chloroethylnitrosourea analogue, which is in phase I clinical trials, is a selective cytotoxin that enters cells via the extraneuronal transporter for monoamine transmitters (EMT).In the present study,we determined EMT expression in 23 human tumor cell lines in order to verify if EMT expression correlate to SarCNU cytotoxicity.Methods:Reverse transcription polymerase chain reaction (RT PCR) was used for determination of EMT expression in tumor cell lines.We also measured expressions of DNA repair protein O6 methylguanine DNA methyltransferase (MGMT) and excision repair cross complementing rodent repair deficiency gene 2 (ERCC2) by Western blot analysis.The results were correlated to SarCNU cytotoxicity which was determined by the sulforhodamine B (SRB) colorimetric anticancer drug screening assay. Results:Almost all of the cell lines tested were positive for EMT expression,while five cell lines (MGR 1,MGR 2,T98 G,SKI 1,and GBM) were very low expressors.Although there was no significant linear correlation between SarCNU cytotoxicity and EMT expression,multiple regression analysis demonstrated a significant correlation between SarCNU cytotoxicity and EMT plus MGMT and ERCC 2 expression. Conclusions:This study suggests that both EMT and DNA repair factors, specifically,MGMT and ERCC2 are important determinants of SarCNU activity against human tumor cell lines.SarCNU should prove to be a more useful alternative chemotherapeutic agent for treatment of human tumors,since the majority of human tumor cell lines were EMT positive.